Abstract
No public abstract is available from the verified source records.
Juan F. Rodriguez-Riascos, Aakash Somappa, Camilo A. Estrada-Vargas, Dravid Navale, Hema S. Vemulapalli, James Y. Kim, Omar J. Baqal, Anil Sriramoju
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Renal Disease and Atrial Fibrillation
10.1016/j.ccep.2020.11.001 · 2021
Chronic Kidney Disease with Mild and Mild to Moderate Reduction in Renal Function and Long-Term Recurrences of Atrial Fibrillation after Pulmonary Vein Cryoballoon Ablation
10.3390/jcdd9050126 · 2022
Temporal trends and in-hospital complications of catheter ablation for atrial fibrillation among patients with moderate and advanced chronic kidney diseases: 2005-2018
10.1111/jce.15354 · 2022
Evaluating Pulsed Field Ablation for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Procedural Outcomes
10.1111/pace.70082 · 2026
Safety, Efficacy, and Mid-Term Outcomes of Pulsed Field Ablation for Cavotricuspid Isthmus-Dependent Flutter: Real-World Data From a Major Health System Registry
10.1161/circep.125.014276 · 2025
Safety and Efficacy of Pulsed Field Ablation for Cavotricuspid Isthmus-Dependent Flutter: A Systematic Literature Review
10.1111/jce.16719 · 2025
Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study
10.1038/s41591-024-03114-3 · 2024
Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US
10.1016/j.jacc.2025.10.051 · 2026
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
Renal safety of high-dose pulsed field ablation of atrial fibrillation: A prospective real-world analysis
10.1016/j.hrthm.2025.07.026 · 2026
Hemolysis After Pulsed Field Ablation: Impact of Lesion Number and Catheter-Tissue Contact
2024
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
10.1016/j.kint.2023.10.018 · 2024
Post-pulmonary vein isolation voltage remapping-guided incremental lesions: A feasible strategy to improve long-term outcomes
10.1016/j.hroo.2024.12.015 · 2025
KDIGO clinical practice guidelines for acute kidney injury
10.1159/000339789 · 2012
The blanking interval after atrial fibrillation ablation: time for reassessment with pulsed field energy
2026
Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients WithChronic Kidney Disease
10.1111/jce.13118 · 2017
Left atrial appendage occlusion in patients with end-stage renal disease: an individual patient-level meta-analysis
10.1093/europace/euaf198 · 2025
Pulsed field ablation and the risk of hemolysis-driven acute kidney injury: a systematic review and meta-analysis
10.1007/s10840-025-02206-5 · 2025
Characterization and Clinical Significance of Hemolysis After Pulsed Field Ablation for Atrial Fibrillation: Results of a Multicenter Analysis
10.1161/circep.124.012732 · 2024
Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation
10.1056/nejmoa2307291 · 2023
Dual-energy lattice-tip ablation system for persistent atrial fibrillation: a randomized trial
10.1038/s41591-024-03022-6 · 2024
Pulsed field ablation of the right superior pulmonary vein prevents vagal responses via anterior right ganglionated plexus modulation
10.1016/j.hrthm.2024.01.040 · 2024
Acute Kidney Injury Resulting From Hemoglobinuria After Pulsed-Field Ablation in Atrial Fibrillation: Is it Preventable?
10.1016/j.jacep.2023.12.008 · 2024
Patient vulnerability associated with acute kidney injury after pulsed field ablation: a role for baseline biomarkers and haptoglobin phenotype
10.1016/j.hrthm.2026.04.028 · 2026
Pulsed Field Ablation-Related Hemolysis: Comparison Between Technologies
10.1161/circep.125.014021 · 2025
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation
10.1056/nejmoa2509688 · 2026
Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation: The ALONE-AF Randomized Clinical Trial
10.1001/jama.2025.14679 · 2025
No additional external references are available.